As of November 6, 2026, Sight Sciences, Inc. is a publicly traded company (Nasdaq: SGHT); its largest reported holder is BlackRock, with 5.01% on Schedule 13G of January 21, 2026. The largest insider holding is Staffan Encrantz, a director and 10% owner, with 6,521,203 shares (11.7% of shares outstanding), per Form 4 of June 11, 2026 (Schedule 13G, January 21, 2026).
Is this your company?
About to sign with, pay or invest in Sight Sciences, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Sight Sciences, Inc. a real, registered company?
- Sight Sciences, Inc. files with the SEC under CIK 1531177 (its SEC filings).
- Its shares are listed under the ticker SGHT on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Menlo Park, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Sight Sciences, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Kashif Rashid, Chief Legal Officer (Form 8-K filed 2026-08-10). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names KCK Ltd. (filed 2026-02-04).
Who are Sight Sciences, Inc.'s owners and officers?
Sight Sciences, Inc.: incorporated in Delaware; business address in Menlo Park, California; industry Surgical & Medical Instruments & Apparatus (Form D, 2026-08-10).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-04-08 | Kck LTD. | 2.7% |
| Schedule 13G/A, 2026-02-04 | Kck LTD. | 7% |
| Schedule 13G, 2026-01-21 | Blackrock, Inc. | 5.01% |
Questions about who owns Sight Sciences, Inc.
Who owns Sight Sciences, Inc.?
On this page, one holder's latest ownership filing reports 5% or more of Sight Sciences, Inc.: Blackrock, Inc. (5.01%, Schedule 13G, filed 2026-01-21).
When did Blackrock, Inc. buy into Sight Sciences, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Blackrock, Inc. on this page is the Schedule 13G, filed 2026-01-21, reporting 5.01%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 3 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Sight Sciences, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Sight Sciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Sight Sciences, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
10 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-08-10 | Kashif Rashid | Chief Legal Officer | appointed | 2026-08-10 |
Which insiders own Sight Sciences, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director and 10% owner: 6,521,203 shares (11.7% of shares outstanding), 1,434,283 held directly and 5,086,920 indirectly (Form 4, 2026-06-11).
- , the chief executive and president: 6,092,819 shares (11.0% of shares outstanding) (Form 4, 2026-10-05).
- , the chief technology officer and a director: 1,975,075 shares (3.6% of shares outstanding) (Form 4, 2026-10-05).
- , the chief commercial officer: 832,293 shares (1.5% of shares outstanding) (Form 4, 2025-07-07).
- , the chief operating officer: 639,449 shares (1.2% of shares outstanding) (Form 4, 2026-10-05).
Shares outstanding: 55,578,977 as of 2026-10-29, from the company's latest SEC cover page.
How much has Sight Sciences, Inc. raised?
No fundraising or offering filing from Sight Sciences, Inc. is on file with us.
Keep reading
More on Sight Sciences, Inc. and the records around it.
Sight Sciences, Inc. elsewhere on the record
- Leadership changes Aug 2026
Companies that share a holder
- KCK LTD. also filed stake reports on 1 other company: NeuroPace Inc (Sep 2025)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/sight-sciences